Novartis Investigative Site
Sevlievo, Gabrovo 5400
0 studies enrolling now · 1 studies all time
What they study most
Psoriatic Arthritis
Studies at this site
Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis
— Completed